.png)
Agenzia Italiana del Farmaco
home
Highlights
-
03 Feb 2026
Press releases
Proton Pump Inhibitors (PPIs): AIFA introduces Note ‘N01’
A new Note will regulate the conditions for prescribing Proton Pump Inhibitors (PPIs) covered by the National Health Service.
-
30 Jan 2026
Press releases
Neglected tropical diseases: defending global health
‘Unite, Act and Eliminate’. To join forces, take action and eliminate neglected tropical diseases: this is the call relaunched by the WHO on World Neglected Tropical Diseases Day 2026. AIFA wholeheartedly supports this appeal.
-
29 Jan 2026
Press releases
AIFA monitoring of pharmaceutical expenditure January-September 2025
Expenditure on medicines dispensed through pharmacies open to the public amounted to €6,425 million (6.33% of the FSN), while expenditure on medicines purchased directly by public healthcare facilities amounted to €11,811 million (11.64% of the FSN).
-
28 Jan 2026
Press releases
Cystic fibrosis: the number of patients eligible for free access to new CFTR modulator medicines has been expanded
The Board of Directors' approval covered two orphan drugs, two new molecules, seven generics, three biosimilars and five therapeutic indication extensions.
News
03 Feb 2026
Lists of Class A and Class H medicinal products
List of class A and H medicinal products at 31 August 2025
15 Jan 2026
Transparency Lists
AIFA updates the Transparency Lists
14 Jan 2026
Companies Section
New Features of the Conference and Meeting Authorisation System
07 Jan 2026
Lists of Class A and Class H medicinal products
List of class A and H medicinal products at 31 July 2025
24 Dec 2025
Companies Section
Guidelines for compiling the dossier of a medicinal product for pricing and reimbursement borne by the NHS
22 Dec 2025
Monitoring pharmaceutical expenditure
Biosimilar medicines in Italy: AIFA reports updated
FarmaciLine
Questions regarding drug efficacy, safety and availability
TOLL-FREE NUMBER
Services
Interactive OsMed - The use of medicines in Italy
An interactive consultation of data on the use of medicines in Italy in the general and regional population, described in terms of expenditure, volumes, typology
Media
